Vanda Pharmaceuticals Inc. (VNDA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 519.76M |
| Enterprise Value | 447.53M |
| P/E Ratio | -1.14 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 1.47 |
| Price/Book Ratio | 1.44 |
| Enterprise/Revenue | 1.32 |
| Enterprise/EBITDA | -1.71 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | -1.27 |
| Operating Margin | -0.86 |
| Return On Assets | -0.67 |
| Return On Equity | -0.85 |
| Revenue | 216.11M |
| Revenue/Share | 3.58 |
| Gross Profit | 203.06M |
| EBITDA | -126.73M |
| Net Income | -220.47M |
| Diluted EPS | -3.74 |
| Total Cash | 170.03M |
| Total Cash/Share | 2.82 |
| Total Debt | 22.83M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 1.61 |
| Book Value Per Share | 3.66 |
| 52-Week Change | 14.53 |
| 52-Week High | 9.94 |
| 52-Week Low | 4.27 |
| Moving Average 50 Days | 5.61 |
| Moving Average 200 Days | 6.53 |
| Average Volume | 946,756 |
| Shares Outstanding | 60.14M |
| % Held by Institutions | 84.63 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |